1. Regional, age and sex differences in baseline characteristics of patients enrolled in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS). Issue 4 (13th February 2015) Authors: Bethel, M. A.; Green, J. B.; Milton, J.; Tajar, A.; Engel, S. S.; Califf, R. M.; Holman, R. R.; on behalf of the TECOS Executive Committee Journal: Diabetes, obesity & metabolism Issue: Volume 17:Issue 4(2015:Apr.) Page Start: 395 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Treatment with incretins does not increase the risk of pancreatic diseases compared to older anti‐hyperglycaemic drugs, when added to metformin: real world evidence in people with Type 2 diabetes. Issue 4 (25th October 2018) Authors: Montvida, O.; Green, J. B.; Atherton, J.; Paul, S. K. Journal: Diabetic medicine Issue: Volume 36:Issue 4(2019) Page Start: 491 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗